MedTrace Logo

The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo

NCT04942860 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-09-11

No results posted yet for this study

Summary

The aim of this study is to evaluate the influence of two concentrations of methotrexate on vitiligous lesions in patients with non-segmental vitiligo

Conditions

  • Non-segmental Vitiligo

Interventions

DRUG

1% Methotrexate gel

1% methotrexate gel applied onto a predefined limb

DRUG

0.5% Methotrexate gel

0.5% methotrexate gel applied onto a predefined limb

Sponsors & Collaborators

  • Nicolaus Copernicus University

    lead OTHER

Principal Investigators

  • Rafał Czajkowski, Prof. · Head of Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2023-06-01
Completion
2023-08-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942860 on ClinicalTrials.gov